Fda accepts Purdue Pharma's Targiniq Er Tablets Cii Nda for review

Purdue Pharma L.P. today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for Targiniq ER Tablets CII, for the management of chronic pain.

http://www.news-medical.net/news/20131127/FDA-accepts-Purdue-Pharmas-Targiniq-ER-Tablets-CII-NDA-for-review.aspx